<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>natural immunity Archives - Amazing Health Advances</title>
	<atom:link href="https://amazinghealthadvances.net/tag/natural-immunity/feed/" rel="self" type="application/rss+xml" />
	<link>https://amazinghealthadvances.net/tag/natural-immunity/</link>
	<description>Your hub for fresh-picked health and wellness info</description>
	<lastBuildDate>Wed, 13 Aug 2025 01:33:42 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.8.2</generator>

<image>
	<url>https://amazinghealthadvances.net/wp-content/uploads/2019/08/AHA_Gradient_Bowl-150x150.jpg</url>
	<title>natural immunity Archives - Amazing Health Advances</title>
	<link>https://amazinghealthadvances.net/tag/natural-immunity/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Poll: Almost Half of U.S. Respondents Demand Reevaluation of CDC Vaccine Schedule</title>
		<link>https://amazinghealthadvances.net/poll-almost-half-respondents-demand-reevaluation-of-vaccine-schedule-8672/#utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=poll-almost-half-respondents-demand-reevaluation-of-vaccine-schedule-8672</link>
					<comments>https://amazinghealthadvances.net/poll-almost-half-respondents-demand-reevaluation-of-vaccine-schedule-8672/#respond</comments>
		
		<dc:creator><![CDATA[The AHA! Team]]></dc:creator>
		<pubDate>Wed, 13 Aug 2025 05:33:15 +0000</pubDate>
				<category><![CDATA[Archive]]></category>
		<category><![CDATA[Child Health]]></category>
		<category><![CDATA[Health Disruptors]]></category>
		<category><![CDATA[Lifestyle]]></category>
		<category><![CDATA[Parenting]]></category>
		<category><![CDATA[Vaccines]]></category>
		<category><![CDATA[CDC]]></category>
		<category><![CDATA[CDC guidelines]]></category>
		<category><![CDATA[childhood vaccine]]></category>
		<category><![CDATA[immunization]]></category>
		<category><![CDATA[natural immunity]]></category>
		<category><![CDATA[Natural News]]></category>
		<category><![CDATA[poll]]></category>
		<category><![CDATA[vaccine]]></category>
		<category><![CDATA[vaccine safety]]></category>
		<category><![CDATA[vaccine schedule]]></category>
		<guid isPermaLink="false">https://amazinghealthadvances.net/?p=18060</guid>

					<description><![CDATA[<p>Ramon Tomey via Natural News &#8211; In a striking shift, nearly half of U.S. respondents in an opinion poll now support reexamining the childhood vaccination schedule recommended by the Centers for Disease Control and Prevention (CDC). A poll by Children&#8217;s Health Defense reveals 49.4 percent of respondents favor reviewing the CDC&#8217;s childhood vaccination schedule, while only 29.6 percent oppose changes. Support rises to nearly 60 percent among parents of young children. While 43 percent still back school vaccine requirements, 39 percent argue public education access should not depend on vaccination status. New CDC appointees, including Martin Kulldorff, are scrutinizing vaccine safety, including cumulative effects of ingredients. Critics accuse the panel of promoting &#8220;anti-vaccine&#8221; views. Nearly half (48 percent) support legal recourse for vaccine-related harm, challenging the 1986 law shielding manufacturers from liability. The CDC&#8217;s review of thimerosal in flu shots revisits past autism concerns. The poll reflects eroded trust in vaccine mandates, signaling a shift away from unquestioned acceptance. In a striking shift, nearly half of U.S. respondents in an opinion poll now support reexamining the childhood vaccination schedule recommended by the Centers for Disease Control and Prevention (CDC). The survey, conducted by John Zogby Strategies and commissioned by Children&#8217;s Health Defense (CHD), polled 1,006 respondents from June 24 to 25. It found that 49.4 percent – 23.7 percent strongly support, 25.7 percent somehow support – are in favor of a reevaluation of the CDC&#8217;s vaccine schedule. In contrast, only 29.6 percent of respondents – 15.1 percent strongly oppose, 14.5 percent somewhat oppose – prefer to keep the vaccination schedule as is. The poll&#8217;s results also revealed that support for reviewing the vaccine schedule spikes to almost 60 percent among parents of young children – a demographic directly impacted by the recommendations. Under the current schedule, children must be injected with 70 doses of 15 vaccines by age 18. Meanwhile, 43 percent of respondents still endorse school vaccine mandates. Nevertheless, 39 percent of respondents argue public education access should remain unconditional instead of being contingent on compliance with vaccine mandates. (Related: MASS EXODUS from public schools anticipated after CDC advisory panel unanimously votes to add deadly Covid-19 &#8220;vaccines&#8221; to childhood immunization schedule.) People want vaccine injury accountability The opinion poll&#8217;s results come amid escalating scrutiny of federal vaccine policies, particularly after Health Secretary Robert F. Kennedy Jr. overhauled the CDC&#8217;s Advisory Committee on Immunization Practices (ACIP) with appointees who criticize mainstream vaccine guidance. Central to the controversy is a newly formed CDC work group tasked with studying the cumulative effects of childhood vaccines. &#8220;It is important to evaluate interaction effects between different vaccines, cumulative amounts of vaccine ingredients, and relative timing,&#8221; said new ACIP Chairman Martin Kulldorff during the panel&#8217;s June 25 meeting. His remarks echoed a 2013 National Academy of Medicine report urging deeper research into vaccine safety, a call left unheeded for over a decade. Critics, including mainstream medical groups, accuse the panel of veering toward anti-vaccine ideology. The American Academy of Pediatrics blasted Kulldorff&#8217;s suggestion to delay hepatitis B vaccinations as &#8220;unscientific&#8221; and &#8220;dangerous.&#8221; Typically given at birth, the new ACIP chairman said the injection can be delayed &#8220;unless the mother is hepatitis B positive.&#8221; Yet CHD CEO Mary Holland argues the poll reflects a public revolt against institutional dogma. &#8220;The constant fearmongering and shaming tactics … are not only ineffective, but backfiring,&#8221; she said. &#8220;This data clearly shows that the mainstream media, medical establishment and many politicians fail to hear the serious concerns of half of Americans on these vital issues.&#8221; Equally contentious is the 1986 National Childhood Vaccine Injury Act, which shields manufacturers from liability. Nearly half of respondents – 48 percent – now support legal recourse for vaccine injuries. In contrast, just 34 percent defend the status quo. This debate started in the 1990s, when mercury-based thimerosal first ignited autism concerns. Kennedy has long cited studies linking vaccines to neurological harm, though federal agencies and major medical journals reject those claims. Thimerosal was later removed from most childhood vaccines in 2001. The new ACIP&#8217;s review of thimerosal-preserved flu shots reignites that clash. Whether the CDC&#8217;s review yields policy changes or further polarization, one truth is clear. The era of unquestioned vaccine mandates is over. Sources include: ChildrensHealthDefense.org 1 ChildrensHealthDefense.org 2 [PDF] NBCNews.com Brighteon.com To read the original article, click here</p>
<p>The post <a href="https://amazinghealthadvances.net/poll-almost-half-respondents-demand-reevaluation-of-vaccine-schedule-8672/">Poll: Almost Half of U.S. Respondents Demand Reevaluation of CDC Vaccine Schedule</a> appeared first on <a href="https://amazinghealthadvances.net">Amazing Health Advances</a>.</p>
]]></description>
		
					<wfw:commentRss>https://amazinghealthadvances.net/poll-almost-half-respondents-demand-reevaluation-of-vaccine-schedule-8672/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Antibodies Perform Best After Covid Infection, Not Vaccine</title>
		<link>https://amazinghealthadvances.net/antibodies-perform-best-after-covid-infection-not-vaccine-7852/#utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=antibodies-perform-best-after-covid-infection-not-vaccine-7852</link>
					<comments>https://amazinghealthadvances.net/antibodies-perform-best-after-covid-infection-not-vaccine-7852/#respond</comments>
		
		<dc:creator><![CDATA[AHA Publisher]]></dc:creator>
		<pubDate>Fri, 11 Feb 2022 08:00:07 +0000</pubDate>
				<category><![CDATA[Archive]]></category>
		<category><![CDATA[Coronavirus (Covid-19)]]></category>
		<category><![CDATA[Health Advances]]></category>
		<category><![CDATA[Health Disruptors]]></category>
		<category><![CDATA[Studies]]></category>
		<category><![CDATA[antibodies]]></category>
		<category><![CDATA[antibody-induced immune response]]></category>
		<category><![CDATA[COVID-19]]></category>
		<category><![CDATA[natural immunity]]></category>
		<category><![CDATA[protection from virus]]></category>
		<category><![CDATA[quality of antibodies]]></category>
		<category><![CDATA[reinfection]]></category>
		<category><![CDATA[Virus]]></category>
		<guid isPermaLink="false">https://amazinghealthadvances.net/?p=14125</guid>

					<description><![CDATA[<p>Abigail Klein Leichman via Israel21c &#8211; Over time, the number of SARS-CoV-2 antibodies falls in both previously infected and vaccinated people, but the performance of antibodies improves only after previous infection and not vaccination. This groundbreaking research, led by Dr. Carmit Cohen of Israel’s Sheba Medical Center, will be presented at the European Congress of Clinical Microbiology and Infectious Diseases in April. Cohen’s finding may explain why previously infected patients appear to be better protected against a new Covid infection than those who have only been vaccinated. She and her colleagues analyzed antibody-induced immune response in 130 recovered individuals for up to a year and compared it to 402 matched individuals who were double-vaccinated with the Pfizer vaccine but never had Covid-19. The researchers found that the numbers of antibodies a month after vaccination were higher than those in the Covid-19 recovered patients. However, these numbers declined more steeply in the vaccinated group. While the avidity (antibody performance quality) index was higher in vaccinated individuals than in recovered patients initially, avidity did not significantly change over time in vaccinated individuals but increased gradually in recovered patients. This could explain why double-vaccinated individuals who never contracted Covid-19 are more likely to experience infection after six months. The study also found that, contrary to expectations, antibodies of recovered patients with a body mass index of 30 or higher (in the obese range) were higher at all time points when compared with those with a BMI under 30 (overweight to normal weight range). The obese people who had been previously infected were therefore better protected against future infection. Of all recovered patients, 42 (36%) experienced long Covid including mental health (5%), neurological (9%), cardiovascular (5%) and respiratory (31%) symptoms. The authors conclude: “While the number of antibodies decrease with time in both Covid-19 recovered patients and vaccinated individuals, the quality of antibodies increases following infection but not after vaccination. These results provide specific characteristics of the immune response that may explain the differential protection against Covid-19 in previously infected and vaccinated individuals.” To read the original article click here.</p>
<p>The post <a href="https://amazinghealthadvances.net/antibodies-perform-best-after-covid-infection-not-vaccine-7852/">Antibodies Perform Best After Covid Infection, Not Vaccine</a> appeared first on <a href="https://amazinghealthadvances.net">Amazing Health Advances</a>.</p>
]]></description>
		
					<wfw:commentRss>https://amazinghealthadvances.net/antibodies-perform-best-after-covid-infection-not-vaccine-7852/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>New Study Reveals Antibodies from Fighting COVID-19 Infection Can Last More Than One Year</title>
		<link>https://amazinghealthadvances.net/new-study-reveals-antibodies-from-fighting-covid-19-infection-can-last-more-than-one-year-7601/#utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=new-study-reveals-antibodies-from-fighting-covid-19-infection-can-last-more-than-one-year-7601</link>
					<comments>https://amazinghealthadvances.net/new-study-reveals-antibodies-from-fighting-covid-19-infection-can-last-more-than-one-year-7601/#respond</comments>
		
		<dc:creator><![CDATA[AHA Publisher]]></dc:creator>
		<pubDate>Thu, 07 Oct 2021 07:00:55 +0000</pubDate>
				<category><![CDATA[Coronavirus (Covid-19)]]></category>
		<category><![CDATA[Health Advances]]></category>
		<category><![CDATA[Studies]]></category>
		<category><![CDATA[antibodies]]></category>
		<category><![CDATA[COVID-19 immunity]]></category>
		<category><![CDATA[immune system]]></category>
		<category><![CDATA[immunity]]></category>
		<category><![CDATA[long-lasting protection]]></category>
		<category><![CDATA[natural immunity]]></category>
		<category><![CDATA[neutralizing antibodies]]></category>
		<guid isPermaLink="false">https://amazinghealthadvances.net/?p=12992</guid>

					<description><![CDATA[<p>Steve Warren via CBN News &#8211; A new peer-reviewed study has confirmed what several researchers and even some health professionals have been saying all along: Most people infected with the COVID-19 virus retain the antibodies to continue to fight it – often for many months following their initial infection.  Just The News reports the European Journal of Immunology accepted a study on Sept. 24 from scientists at the Finnish Institute for Health and Welfare, who studied 1,292 subjects eight months after infection for the presence of antibodies. The researchers found that 96% of their test subjects were still carrying antibodies and 66% still had the nucleoprotein IgG antibody. The Immunoglobulin G (IgG) antibody helps your immune system remember how to fight infections like the COVID-19 virus. But the Finnish scientists&#8217; research went even further. They randomly selected 367 subjects from the original study group who were not vaccinated for a year following their infection. The scientists found that 89% of subjects still had neutralizing antibodies, and 36% with the IgG antibody, according to Just The News. Those subjects who had a severe COVID-19 infection had higher antibody levels, anywhere from two to seven times as many antibodies as those with mild infections at least 13 months after contracting the disease, the study noted. Even though the antibodies provided long-lasting protection against the COVID virus, their ability to fight the Alpha, Beta, and Delta variants diminished over a period of several months. However, the neutralizing antibodies &#8220;were only slightly reduced&#8221; in the Alpha variant and &#8220;considerably declined&#8221; in the Beta variant. But &#8220;over 80% of the subjects who had recovered from severe&#8221; COVID-19 infection still had neutralizing antibodies against the Delta variant a year after being infected, the study pointed out. Natural immunity to the COVID-19 virus has been touted by some health professionals throughout the pandemic. Former FDA Commissioner Scott Gottlieb, M.D. told CBN News in September that in addition to taking the vaccine, another way to achieve immunity is through natural means. &#8220;I think we need to recognize that people who have immunity that&#8217;s acquired through infection, that immunity is durable, and it appears it is quite robust,&#8221; he said. &#8220;I think the question from a clinical standpoint is how long it&#8217;s going to last.&#8221; As CBN News reported in August, a George Mason University (GMU) law professor who sued the school over its COVID-19 vaccine mandate was ultimately granted a medical exemption by the school. Todd Zywicki, the law professor at the Fairfax, Virginia, school said he had COVID-19 and defeated it, therefore his natural immunity, he argued, should prevent him from having to get the vaccination. According to University Business, Zywicki claimed the vaccine mandate enforced by the school was excessive since he already had natural immunity through antibodies he acquired after he successfully recovered from the virus. His attorneys revealed Zywicki took six tests to prove those antibodies were still active in his immune system. Dr. Marty Makary, a professor at Johns Hopkins School of Public Health, told CBN Newsin late June that medical experts got it wrong when they dismissed natural immunity to the virus. &#8220;It&#8217;s one of the biggest failures of our medical establishment to dismiss natural immunity,&#8221; he told CBN News, pointing to two new studies that show its efficacy. &#8220;It works. It&#8217;s durable. You may not need the vaccine and it&#8217;s probably long-lasting. It&#8217;s probably life-long.&#8221; In a U.S. News &#38; World Report op-ed published later in August, Makary said an Israeli study showed natural immunity is 6.7 times greater than for vaccinated people. To read the original article click here.</p>
<p>The post <a href="https://amazinghealthadvances.net/new-study-reveals-antibodies-from-fighting-covid-19-infection-can-last-more-than-one-year-7601/">New Study Reveals Antibodies from Fighting COVID-19 Infection Can Last More Than One Year</a> appeared first on <a href="https://amazinghealthadvances.net">Amazing Health Advances</a>.</p>
]]></description>
		
					<wfw:commentRss>https://amazinghealthadvances.net/new-study-reveals-antibodies-from-fighting-covid-19-infection-can-last-more-than-one-year-7601/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>
